Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,245 | 951 | 99.1% |
| Education | $132.04 | 9 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,972 | 163 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,461 | 68 | $0 (2024) |
| Amgen Inc. | $1,362 | 90 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,321 | 98 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,008 | 76 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $950.55 | 68 | $0 (2024) |
| ABBVIE INC. | $881.60 | 58 | $0 (2024) |
| Lilly USA, LLC | $749.22 | 49 | $0 (2024) |
| PFIZER INC. | $531.26 | 50 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $520.23 | 37 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,526 | 139 | AstraZeneca Pharmaceuticals LP ($442.44) |
| 2023 | $2,390 | 142 | Novo Nordisk Inc ($408.46) |
| 2022 | $2,142 | 136 | ABBVIE INC. ($267.52) |
| 2021 | $2,090 | 133 | AstraZeneca Pharmaceuticals LP ($212.99) |
| 2020 | $1,225 | 84 | AstraZeneca Pharmaceuticals LP ($235.12) |
| 2019 | $1,517 | 126 | Novo Nordisk Inc ($341.79) |
| 2018 | $1,458 | 127 | GlaxoSmithKline, LLC. ($194.22) |
| 2017 | $1,030 | 73 | AstraZeneca Pharmaceuticals LP ($217.77) |
All Payment Transactions
960 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Bone Health | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: Inflammation | ||||||
| 12/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.74 | General |
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,823 | 4,345 | $361,813 | $217,573 |
| 2022 | 27 | 1,870 | 4,671 | $370,748 | $217,075 |
| 2021 | 28 | 2,022 | 4,832 | $380,666 | $223,690 |
| 2020 | 27 | 1,717 | 3,728 | $320,904 | $167,491 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 335 | 869 | $144,055 | $70,052 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 277 | 277 | $41,550 | $33,989 | 81.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,500 | $37,125 | $27,247 | 73.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 124 | 263 | $19,725 | $12,153 | 61.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 145 | 145 | $13,050 | $10,430 | 79.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 39 | 44 | $15,400 | $8,880 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 130 | $14,355 | $8,081 | 56.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 64 | $9,600 | $6,335 | 66.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 152 | 153 | $6,885 | $4,506 | 65.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 80 | 125 | $6,875 | $4,419 | 64.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 85 | 101 | $6,565 | $3,976 | 60.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,400 | $3,946 | 89.7% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 63 | $5,040 | $3,357 | 66.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 26 | $5,675 | $3,163 | 55.7% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 76 | 79 | $3,555 | $3,102 | 87.3% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 19 | 19 | $3,800 | $2,717 | 71.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $4,080 | $2,548 | 62.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $1,925 | $1,739 | 90.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 19 | 22 | $3,300 | $1,056 | 32.0% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 12 | 12 | $1,500 | $1,033 | 68.8% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 19 | 25 | $1,375 | $813.50 | 59.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 81 | 91 | $3,640 | $809.56 | 22.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 19 | 19 | $950.00 | $746.13 | 78.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 17 | 152 | $2,128 | $638.40 | 30.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 16 | $1,870 | $434.76 | 23.2% |
About Dr. John Weston, MD
Dr. John Weston, MD is a Internal Medicine healthcare provider based in Lewisburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861474371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Weston, MD has received a total of $14,377 in payments from pharmaceutical and medical device companies, with $2,526 received in 2024. These payments were reported across 960 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($14,245).
As a Medicare-enrolled provider, Weston has provided services to 7,432 Medicare beneficiaries, totaling 17,576 services with total Medicare billing of $825,829. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lewisburg, PA
- Active Since 11/18/2005
- Last Updated 12/29/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861474371
Products in Payments
- FARXIGA (Drug) $999.52
- XARELTO (Drug) $918.42
- Ozempic (Drug) $872.47
- TRELEGY ELLIPTA (Drug) $860.70
- Otezla (Drug) $447.63
- Rybelsus (Drug) $436.25
- EVENITY (Biological) $412.87
- UBRELVY (Drug) $374.89
- MOUNJARO (Drug) $362.54
- STIOLTO RESPIMAT (Drug) $361.21
- TRADJENTA (Drug) $346.83
- SOLIQUA 100/33 (Biological) $282.10
- NURTEC ODT (Drug) $277.83
- VRAYLAR (Drug) $270.59
- Prolia (Biological) $269.65
- JARDIANCE (Drug) $244.20
- Aimovig (Biological) $209.39
- ENTRESTO (Drug) $207.38
- Kerendia (Drug) $205.06
- Victoza (Drug) $203.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lewisburg
Danny Cho, Md, MD
Internal Medicine — Payments: $18,942
Dr. Jillian Douglas, D.o, D.O
Internal Medicine — Payments: $3,537
Dr. Saquib Siddiqi, Do, DO
Internal Medicine — Payments: $2,873
Christopher Moll, Do, DO
Internal Medicine — Payments: $1,731
Melanie Patel, D.o, D.O
Internal Medicine — Payments: $893.71
Dr. Malcolm Mar Fan, M.d, M.D
Internal Medicine — Payments: $796.23